Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China · Delayed Price · Currency is CNY 22.27
+0.51 (2.34%)
Jun 18, 2026, 11:19 AM CST
SHA:603983 Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, SHA:603983 stock has a consensus rating of "Buy" and an average price target of ¥28.17. The average 1-year stock price forecast is 26.49% higher than the current stock price, while the lowest is ¥23.00 (+3.28%) and the highest is ¥33.50 (+50.43%).
Price Target: ¥28.17 (+26.49%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:603983 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 4 | 4 | 5 | 5 |
| Buy | 3 | 3 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 13 | 12 | 10 | 9 | 9 | 9 |
Financial Forecast
Revenue This Year
4.04B
from 3.46B
Increased by 16.83%
Revenue Next Year
4.55B
from 4.04B
Increased by 12.71%
EPS This Year
0.87
from 0.58
Increased by 50.00%
EPS Next Year
1.09
from 0.87
Increased by 25.77%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.3B | ||
| Avg | 4.0B | ||
| Low | 3.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 23.9% | ||
| Avg | 16.8% | ||
| Low | 9.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.87 | ||
| Avg | 0.87 | ||
| Low | 0.87 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 50.0% | ||
| Avg | 50.0% | ||
| Low | 50.0% |